Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | CRL | JNJ |
|---|
| Close | 273.41 | 267.28 |
| Market Cap | $13.1B | $644B |
| 1M | −4.62% | +1.87% |
| P/E (TTM) | — | 30.6 |
| Forward P/E | 24.2 | 20.7 |
| P/E 5-Yr Percentile | — | 90 |
| P/S | 3.3 | 6.6 |
| P/B | 4.6 | 7.6 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $1.0B | $25.3B |
| Revenue YoY | −2.7% | +6.6% |
| Gross Margin | — | 68.2% |
| Latest Quarter EPS | -0.03 | 2.27 |
| Avg Post-Earnings Move | ±1.8% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 1.25% |
| 90-Day Net Insider Buying | −$42.6M | −$67.8M |
CRL · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
